(Q37670194)

21 August 2017

1 reference

title

Emerging therapy for the treatment of acute lymphoblastic leukemia (English)

1 reference

21 August 2017

1 reference

3

Hagop Kantarjian

1 reference

21 August 2017

2

Susan O'Brien

1 reference

21 August 2017

4

Elias Jabbour

1 reference

21 August 2017

1

Amber Fullmer

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

Expert Opinion on Emerging Drugs

21 August 2017

published in

1 reference

21 August 2017

volume

15

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

1-11

1 reference

21 August 2017

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Outcome of adults with acute lymphocytic leukemia after second salvage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Acute lymphocytic leukaemia in the elderly: characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Cognitive sequelae of brain radiation in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Minimal neuropsychological sequelae following prophylactic treatment of the central nervous system in adult leukaemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

High-dose methotrexate: a critical reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Central nervous system prophylaxis in haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

High-dose methotrexate in the treatment of adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Initial testing of dasatinib by the pediatric preclinical testing program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

The clinical significance of detection of residual disease in childhood ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Studies of minimal residual disease in acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Risk-adapted treatment according to minimal residual disease in adult ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

Clofarabine for the treatment of acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903456026

10.1517/14728210903456026

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference